| Control (n = 25) | Sarcoidosis and normal spirometry (n = 24) | Sarcoidosis and altered spirometry (n = 23) | ANOVA p |
---|---|---|---|---|
Age (years) | 59.1 ± 10.5 | 48.6 ± 11.2 | 47.8 ± 11.2 | ns |
Body mass (kg) | 67.6 ± 15.1 | 68.2 ± 13.2 | 73.4 ± 15.5 | ns |
Height (m) | 1.6 ± 0.1 | 1.6 ± 0.1 | 1.7 ± 0.1 | 0.019 |
BMI (kg/m2) | 26.7 ± 5.0 | 26.8 ± 5.2 | 26.3 ± 4.5 | ns |
Male/Female | 6/19 | 5/19 | 9/14 | – |
FVC (L) | 3.1 ± 0.9 | 3.1 ± 0.8 | 3.2 ± 1.4 | ns |
FVC (%) | 100.2 ± 20.3 | 99.2 ± 18.1 | 86.2 ± 28.8 | ns |
FEV1 (L) | 2.5 ± 0.7 | 2.5 ± 0.7 | 2.2 ± 0.9 | ns |
FEV1 (%) | 100.0 ± 21.3 | 96.4 ± 17.8 | 74.5 ± 23.8 | 0.0001 |
FEV1/FVC | 80.3 ± 6.5 | 80.6 ± 6.8 | 72.0 ± 8.5 | 0.0001 |
FEV1/FVC (%) | 99.8 ± 7.1 | 97.8 ± 8.3 | 87.3 ± 9.6 | 0.0001 |
FEF25–75% (L) | 2.7 ± 1.2 | 2.9 ± 1.1 | 1.7 ± 0.7 | 0.0003 |
FEF25–75% (%) | 110.7 ± 45.9 | 96.6 ± 44.0 | 51.0 ± 19.6 | 0.0001 |